Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
   B01 ANTITHROMBOTIC AGENTS
   B02 ANTIHEMORRHAGICS
   B03 ANTIANEMIC PREPARATIONS
     B03A IRON PREPARATIONS
     B03B VITAMIN B12 AND FOLIC ACID
       B03BA Vitamin B12 (cyanocobalamin and analogues)
         B03BA01 Cyanocobalamin
         B03BA02 Cyanocobalamin tannin complex
         B03BA03 Hydroxocobalamin [DG:DG00175]
           D01027  Hydroxocobalamin (JAN/USP/INN) <US>
           D02707  Hydroxocobalamin acetate (JP18) <JP/US>
           D04929  Hydroxocobalamin hydrochloride (JAN)
         B03BA04 Cobamamide
         B03BA05 Mecobalamin
         B03BA51 Cyanocobalamin, combinations
         B03BA53 Hydroxocobalamin, combinations
       B03BB Folic acid and derivatives
     B03X OTHER ANTIANEMIC PREPARATIONS
   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
   B06 OTHER HEMATOLOGICAL AGENTS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS
   V01 ALLERGENS
   V03 ALL OTHER THERAPEUTIC PRODUCTS
     V03A ALL OTHER THERAPEUTIC PRODUCTS
       V03AB Antidotes
         V03AB01 Ipecacuanha
         V03AB02 Nalorphine [DG:DG01151]
         V03AB03 Edetates [DG:DG01152]
         V03AB04 Pralidoxime [DG:DG01153]
         V03AB05 Prednisolone and promethazine
         V03AB06 Thiosulfate
         V03AB08 Sodium nitrite
         V03AB09 Dimercaprol
         V03AB13 Obidoxime
         V03AB14 Protamine [DG:DG01154]
         V03AB15 Naloxone [DG:DG01155]
         V03AB16 Ethanol [DG:DG00430]
         V03AB17 Methylthioninium chloride [DG:DG01156]
         V03AB18 Potassium permanganate
         V03AB19 Physostigmine [DG:DG01132]
         V03AB20 Copper sulfate
         V03AB21 Potassium iodide
         V03AB22 Amyl nitrite
         V03AB23 Acetylcysteine [DG:DG01069]
         V03AB24 Digitalis antitoxin
         V03AB25 Flumazenil
         V03AB26 Methionine [DG:DG01157]
         V03AB27 4-dimethylaminophenol
         V03AB29 Cholinesterase
         V03AB31 Prussian blue
         V03AB32 Glutathione [DG:DG01158]
         V03AB33 Hydroxocobalamin [DG:DG00175]
           D01027  Hydroxocobalamin (JAN/USP/INN) <US>
           D02707  Hydroxocobalamin acetate (JP18) <JP/US>
           D04929  Hydroxocobalamin hydrochloride (JAN)
         V03AB34 Fomepizole
         V03AB35 Sugammadex
         V03AB36 Phentolamine [DG:DG00280]
         V03AB37 Idarucizumab
         V03AB38 Andexanet alfa
         V03AB54 Pralidoxime and atropine
       V03AC Iron chelating agents
       V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
       V03AF Detoxifying agents for antineoplastic treatment
       V03AG Drugs for treatment of hypercalcemia
       V03AH Drugs for treatment of hypoglycemia
       V03AK Tissue adhesives
       V03AM Drugs for embolisation
       V03AN Medical gases
       V03AX Other therapeutic products
       V03AZ Nerve depressants
   V04 DIAGNOSTIC AGENTS
   V06 GENERAL NUTRIENTS
   V07 ALL OTHER NON-THERAPEUTIC PRODUCTS
   V08 CONTRAST MEDIA
   V09 DIAGNOSTIC RADIOPHARMACEUTICALS
   V10 THERAPEUTIC RADIOPHARMACEUTICALS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: March 6, 2024
According to WHO's ATC 2024

» Japanese version